MASSAFFINITY Trademark
Trademark Overview
On Monday, July 1, 2024, a trademark application was filed for MASSAFFINITY with the United States Patent and Trademark Office. The USPTO has given the MASSAFFINITY trademark a serial number of 79403944. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Saturday, May 24, 2025. This trademark is owned by MassAffinity Pty Limited. The MASSAFFINITY trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Providing information relating to drugs, namely, providing medical information to medical professionals in the form of reports in the field of pharmaceutical interactions; drug information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; provision of information relating to drugs, namely, providing medical information to medical professionals in the form of reports in the field of pharmaceutical interactions; advisory services relating to drugs, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
Pharmaceutical drug development; drug discovery services, namely, development of pharmaceutical preparations and medicines; pharmaceutical research and development; drug development services; development of pharmaceuticals; development of pharmaceutical preparations and medicines; research and development of new products for the pharmaceutical industry; research and development services of new pharmaceutical products; scientific research and development; research to develop new products; conducting early evaluations in the field of new pharmaceuticals; research in the field of pharmaceuticals; research and development services for the pharmaceutical industry; biochemical research and development; laboratory research in the field of pharmaceuticals; scientific research in the field of pharmacogenomics; research and development services in the field of pharmaceutical preparations; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; p...
General Information
| Serial Number | 79403944 |
| Word Mark | MASSAFFINITY |
| Filing Date | Monday, July 1, 2024 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Saturday, May 24, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Pseudo Mark | MASS AFFINITY |
| Goods and Services | Providing information relating to drugs, namely, providing medical information to medical professionals in the form of reports in the field of pharmaceutical interactions; drug information services, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; provision of information relating to drugs, namely, providing medical information to medical professionals in the form of reports in the field of pharmaceutical interactions; advisory services relating to drugs, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals |
| Goods and Services | Pharmaceutical drug development; drug discovery services, namely, development of pharmaceutical preparations and medicines; pharmaceutical research and development; drug development services; development of pharmaceuticals; development of pharmaceutical preparations and medicines; research and development of new products for the pharmaceutical industry; research and development services of new pharmaceutical products; scientific research and development; research to develop new products; conducting early evaluations in the field of new pharmaceuticals; research in the field of pharmaceuticals; research and development services for the pharmaceutical industry; biochemical research and development; laboratory research in the field of pharmaceuticals; scientific research in the field of pharmacogenomics; research and development services in the field of pharmaceutical preparations; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing information about medical and scientific research in the field of pharmaceuticals; product development consultancy for inventors in the field of molecular biology; research and development in the field of biochemistry |
Classification Information
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 5, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, September 5, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | MassAffinity Pty Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | AU |
Trademark Events
| Event Date | Event Description |
| Thursday, September 5, 2024 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, September 9, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, September 9, 2024 | APPLICATION FILING RECEIPT MAILED |
| Sunday, December 29, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, December 27, 2024 | ASSIGNED TO EXAMINER |
| Monday, December 30, 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, January 31, 2025 | REFUSAL PROCESSED BY MPU |
| Friday, January 31, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Friday, May 23, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Saturday, February 22, 2025 | REFUSAL PROCESSED BY IB |
| Friday, May 23, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, May 23, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, May 24, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
